Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate

NCT02715947 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT02715947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02715947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
Lead sponsor
Central South University
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2015
Completion date
December 31, 2017
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris